| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |